Abstract
This review chapter describes the current knowledge about the nature of pericytes in the gut, their interaction with endothelial cells in blood vessels, and their pathophysiological functions in the setting of chronic liver disease. In particular, it focuses on the role of these vascular cell types and related molecular signaling pathways in pathological angiogenesis associated with liver disease and in the establishment of the gut-vascular barrier and the potential implications in liver disease through the gut-liver axis.
Keywords
Marta Ramirez and Nuria Pell are Co-first authors.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Abraldes JG, Iwakiri Y, Loureiro-Silva M et al (2006) Mild increases in portal pressure upregulate vascular endothelial growth factor and endothelial nitric oxide synthase in the intestinal microcirculatory bed, leading to a hyperdynamic state. Am J Phys 290:G980–G987
Alverdy JC (1990) Effects of glutamine-supplemented diets on immunology of the gut. JPEN 14:109S–113S
Armulik A, Genove G, Mäe M et al (2010) Pericytes regulate the blood–brain barrier. Nature 468:557–561
Armulik A, Genove G, Betsholtz C (2011) Pericytes: developmental, physiological, and pathological perspectives, problems, and promises. Dev Cell 21:193–215
Artis D (2008) Epithelial-cell recognition of commensal bacteria and maintenance of immune homeostasis in the gut. Nat Rev Immunol 8:411–420
Backhed F, Ley RE, Sonnenburg JL et al (2005) Host-bacterial mutualism in the human intestine. Science 307:1915–1920
Bain CC, Mowat AM (2014) Macrophages in intestinal homeostasis and inflammation. Immunol Rev 260:102–117
Bava FA, Eliscovich C, Ferreira PG et al (2013) CPEB1 coordinates alternative 3’-UTR formation with translational regulation. Nature 495:121–125
Bergers G, Song S (2005) The role of pericytes in blood-vessel formation and maintenance. Neuro-Oncology 7:452–464
Bergers G, Song S, Meyer-Morse M et al (2003) Benefits of targeting both pericytes and endothelial cells in the tumor vasculature with kinase inhibitors. J Clin Invest 111:1287–1295
Bhat M, Arendt BA, Bhat V et al (2016) Implication of the intestinal microbiome in complications of cirrhosis. World J Hepatol 8:1128–1136
Calderone V, Gallego J, Fernandez-Miranda G et al (2016) Sequential functions of CPEB1 and CPEB4 regulate pathologic expression of VEGF and angiogenesis in chronic liver disease. Gastroenterology 150:982–997
Chatterjee S (2014) Reversal of vasohibin-driven negative feedback loop of vascular endothelial growth factor/angiogenesis axis promises a novel antifibrotic therapeutic strategy for liver diseases. Hepatology 60:458–460
Coch L, Mejias M, Berzigotti A et al (2014) Disruption of negative feedback loop between vasohibin-1 and VEGF decreases portal pressure, angiogenesis and fibrosis in cirrhotic rats. Hepatology 60:633–647
Coffey JC, O’Leary DP (2016) The mesentery: structure, function, and role in disease. Lancet Gastroenterol Hepatol 1:238–247
Daneman R, Zhou L, Kebede AA et al (2010) Pericytes are required for blood–brain barrier integrity during embryogenesis. Nature 468:562–566
Drake RL, Vogl AW, Mitchell A (2015) Gray’s anatomy for students, 3rd edn. Churchill Livingstone/Elsevier, Philadelphia, PA, pp 271–275
Fernandez M (2015) Molecular pathophysiology of portal hypertension. Hepatology 61:1406–1415
Fernandez M, Vizzutti F, Garcia-Pagan JC et al (2004) Anti-VEGF receptor-2 monoclonal antibody prevents portal-systemic collateral vessel formation in portal hypertensive mice. Gastroenterology 126:886–894
Fernandez M, Mejias M, Angermayr B et al (2005) Inhibition of VEGF receptor-2 decreases the development of hyperdynamic splanchnic circulation and portal-systemic collateral vessels in portal hypertensive rats. J Hepatol 43:98–103
Fernandez M, Mejias M, Garcia-Pras E et al (2007) Reversal of portal hypertension and hyperdynamic splanchnic circulation by combined vascular endothelial growth factor and platelet-derived growth factor blockade in rats. Hepatology 46:1208–1217
Fernandez M, Semela D, Bruix J et al (2009) Angiogenesis in liver disease. J Hepatol 50:604–620
Fernandez-Miranda G, Mendez R (2012) The CPEB-family of proteins, translational control in senescence and cancer. Ageing Res Rev 11:460–472
Gaengel K, Genove G, Armulik A et al (2009) Endothelial-mural cell signaling in vascular development and angiogenesis. Arterioscler Thromb Vasc Biol 29:630–638
Gallego J, Garcia-Pras E, Mejias M et al (2017) Therapeutic siRNA targeting endothelial KDR decreases portosystemic collateralization in portal hypertension. Sci Rep 7:14791
Garcia-Pras E, Gallego J, Coch L et al (2017) Role and therapeutic potential of vascular stem/progenitor cells in pathological neovascularisation during chronic portal hypertension. Gut 66:1306–1320
Garcia-Tsao G, Bosch J (2010) Management of varices and variceal hemorrhage in cirrhosis. N Engl J Med 362:823–832
Garcia-Tsao G, Sanyal AJ, Grace N et al (2007) Prevention and management of gastroesophageal varices and variceal hemorrhage in cirrhosis. Hepatology 46:922–938
Garrett WS, Gordon JI, Glimcher LH (2010) Homeostasis and inflammation in the intestine. Cell 140:859–870
Gerhardt H, Golding M, Fruttiger M et al (2003) VEGF guides angiogenic sprouting utilizing endothelial tip cell filopodia. J Cell Biol 161:1163–1177
Granger DN, Holm L, Kvietys PR (2015) The gastrointestinal circulation: physiology and pathophysiology. In: Terjung R (ed) Comprehensive physiology. Wiley, Hoboken, NJ. https://doi.org/10.1002/cphy.c150007
Gray H, Lewis WH (2000) Gray’s anatomy of the human body, 20th edn. Bartleby, New York, NY
Guarner C, Soriano G, Tomas A et al (1993) Increased serum nitrite and nitrate levels in patients with cirrhosis: relationship to endotoxemia. Hepathology 18:1139–1143
Gupta TK, Toruner M, Chung MK et al (1998) Endothelial dysfunction and decreased production of nitric oxide in the intrahepatic microcirculation of cirrhotic rats. Hepatology 28:926–931
Harper D, Chandler B (2016) Splanchnic circulation. BJA Education 16:66–71
Hirschi K, D’Amore PA (1996) Pericytes in the microvasculature. Cardiovasc Res 32:687–698
Iwakiri Y, Shah V, Rockey DC (2014) Vascular pathobiology in chronic liver disease and cirrhosis - current status and future directions. J Hepatol 61:912–924
Jacobson ED (1982) Physiology of the mesenteric circulation. Physiologist 25:439–443
Jakobsson L, Franco CA, Bentley K et al (2010) Endothelial cells dynamically compete for the tip cell position during angiogenic sprouting. Nat Cell Biol 12:943–953
Jankowski JA, Goodlad RA, Wright NA (1994) Maintenance of normal intestinal mucosa: function, structure, and adaptation. Gut 35(Suppl 1):S1–S4
Kachlik D, Baca V, Stingl J (2010) The spatial arrangement of the human large intestinal wall blood circulation. J Anat 216:335–343
Kelly-Goss MR, Sweat RS, Stapor PC et al (2014) Targeting pericytes for angiogenic therapies. Microcirculation 21:345–357
Kvietys PR (2010) The gastrointestinal circulation (chap. 2: anatomy). Morgan & Claypool Life Sciences, San Rafael, CA
Liebner S, Corada M, Bangsow T et al (2008) Wnt/−catenin signaling controls development of the blood—brain barrier. J Cell Biol 183:409–417
Llovet JM, Bruix J (2009) Testing molecular therapies in hepatocellular carcinoma: the need for randomized phase II trials. J Clin Oncol 27:833–835
Maillo C, Martin J, Sebastian D et al (2017) Circadian- and UPR-dependent control of CPEB4 mediates a translational response to counteract hepatic steatosis under ER stress. Nat Cell Biol 19:94–105
Matheson PJ, Wilson MA, Garrison RN (2000) Regulation of intestinal blood flow. J Surg Res 93:182–196
Mejias M, Garcia-Pras E, Tiani C et al (2009) Beneficial effects of sorafenib on splanchnic, intrahepatic, and portocollateral circulations in portal hypertensive and cirrhotic rats. Hepatology 49:1245–1256
Mejias M, Coch L, Berzigotti A et al (2015) Antiangiogenic and antifibrogenic activity of pigment epithelium-derived factor (PEDF) in bile duct-ligated portal hypertensive rats. Gut 64:657–666
Mendez R, Hake LE, Andresson T et al (2000a) Phosphorylation of CPE binding factor by Eg2 regulates translation of c-Mos mRNA. Nature 404:302–307
Mendez R, Murthy KG, Ryan K et al (2000b) Phosphorylation of CPEB by Eg2 mediates the recruitment of CPSF into an active cytoplasmic polyadenylation complex. Mol Cell 6:1253–1259
Ortiz-Zapater E, Pineda D, Martínez-Bosch N et al (2011) Key contribution of CPEB4-mediated translational control to cancer progression. Nat Med 18:83–90
Phillips GB, Schwartz R, Gabuzda GJ Jr et al (1952) The syndrome of impending hepatic coma in patients with cirrhosis of the liver given certain nitrogenous substances. N Engl J Med 247:239–246
Pinter M, Sieghart W, Reiberger T et al (2012) The effects of sorafenib on the portal hypertensive syndrome in patients with liver cirrhosis and hepatocellular carcinoma-a pilot study. Aliment Pharmacol Ther 35:83–91
Pique M, Lopez JM, Foissac S et al (2008) A combinatorial code for CPE-mediated translational control. Cell 132:434–448
Potente M, Gerhardt H, Carmeliet P (2011) Basic and therapeutic aspects of angiogenesis. Cell 146:873–887
Reiberger T, Angermayr B, Schwabl P et al (2009) Sorafenib attenuates the portal hypertensive syndrome in partial portal vein ligated rats. J Hepatol 51:865–873
Reiberger T, Payer BA, Schwabl P et al (2013) Nebivolol treatment increases splanchnic blood flow and portal pressure in cirrhotic rats via modulation of nitric oxide signalling. Liver Int 33:561–568
Rockey DC, Chung JJ (1998) Reduced nitric oxide production by endothelial cells in cirrhotic rat liver: endothelial dysfunction in portal hypertension. Gastroenterology 114:344–351
Sarkissian M, Mendez R, Richter JD (2004) Progesterone and insulin stimulation of CPEB-dependent polyadenylation is regulated by Aurora a and glycogen synthase kinase-3. Genes Dev 18:48–61
Schnabl B, Brenner DA (2014) Interactions between the intestinal microbiome and liver diseases. Gastroenterology 146:1513–1524
Schuppan D, Afdhal NH (2008) Liver cirrhosis. Lancet 371:838–851
Sharara AI, Rockey DC (2001) Gastroesophageal variceal hemorrhage. N Engl J Med 345:669–681
Spadoni I, Zagato E, Bertocchi A et al (2015) A gut-vascular barrier controls the systemic dissemination of bacteria. Science 350:830–834
Spadoni I, Pietrelli A, Pesole G et al (2016) Gene expression profile of endothelial cells during perturbation of the gut vascular barrier. Gut Microbes 7:540–548
Sparks HV (2011) Effect of local metabolic factors on vascular smooth muscle. Supplement 7: handbook of physiology, the cardiovascular system, vascular smooth muscle, pp 475–513
Stapor PC, Sweat RS, Dashti DC et al (2014) Pericyte dynamics during angiogenesis: new insights from new identities. J Vasc Res 51:163–174
Thorburn T, Aali M, Lehmann C (2018) Immune response to systemic inflammation in the intestinal microcirculation. Front Biosci (Landmark Ed) 23:782–795
Tsiaoussis GI, Assimakopoulos SF, Tsamandas AC et al (2015) Intestinal barrier dysfunction in cirrhosis: current concepts in pathophysiology and clinical implications. World J Hepatol 7:2058–2068
Tugues S, Fernandez-Varo G, Muñoz-Luque J et al (2007) Antiangiogenic treatment with sunitinib ameliorates inflammatory infiltrate, fibrosis, and portal pressure in cirrhotic rats. Hepatology 46:1919–1926
Usami M, Miyoshi M, Yamashita H (2015) Gut microbiota and host metabolism in liver cirrhosis. World J Gastroenterol 21:11597–11608
Van Steenkiste C, Geerts A, Vanheule E et al (2009) Role of placental growth factor in mesenteric neoangiogenesis in a mouse model of portal hypertension. Gastroenterology 137:2112–2124
Vespasiani-Gentilucci U, Rombouts K (2015) Boosting pigment epithelial-derived factor: a promising approach for the treatment of early portal hypertension. Gut 64:523–524
Volta U, Bonazzi C, Bianchi FB et al (1987) IgA antibodies to dietary antigens in liver cirrhosis. Ric Clin Lab 17:235–242
Grant Support
This is supported by grants from the Spanish Ministry of Economy and Competitiveness (MINECO; SAF2014–55473-R and BES2015–071399); the Spanish Ministry of Science, Innovation and Universities (SAF2017–87988-R); the European Union FEDER funds; the Spanish Association Against Cancer (AECC); the Worldwide Cancer Research Foundation; and the CERCA Programme (Generalitat de Catalunya, Spain). CIBERehd is an initiative from the Instituto de Salud Carlos III.
Disclosures All authors declare no competing financial interests.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Ramirez, M., Pell, N., Mejias, M., Fernandez, M. (2019). Pericytes in the Gut. In: Birbrair, A. (eds) Pericyte Biology in Different Organs. Advances in Experimental Medicine and Biology, vol 1122. Springer, Cham. https://doi.org/10.1007/978-3-030-11093-2_5
Download citation
DOI: https://doi.org/10.1007/978-3-030-11093-2_5
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-11092-5
Online ISBN: 978-3-030-11093-2
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)